BioAge Labs is a clinical-stage biotechnology company that operates in the healthcare sector, specifically focusing on the development of therapies for age-related diseases. The company's primary mission is to map human aging and use this information to create a range of treatments that not only combat diseases but also extend a healthy lifespan.

Their business model revolves around their unique human-first discovery platform. This platform translates insights from human aging profiles into a diverse portfolio of drugs. These drugs are then used to create medicines that treat or prevent diseases of aging in entirely new ways. Essentially, BioAge Labs is redefining the concept of healthy aging with their longevity-focused therapeutics.

The company's target market includes individuals suffering from age-related diseases, a group that represents a significant unmet medical need. By focusing on this market, BioAge Labs is positioning itself at the forefront of a key moment of opportunity for longevity medicine.

BioAge Labs makes money by developing and selling their unique, longevity-focused therapeutics. As they progress through the clinical stages and their drugs receive approval, they will be able to sell these treatments to healthcare providers and patients.

In summary, BioAge Labs is a pioneering biotechnology company that is using innovative technology and scientific progress to develop treatments for age-related diseases and extend healthy human lifespan.

Keywords: Biotechnology, Clinical-Stage, Human Aging, Therapies, Disease Treatment, Longevity Medicine, Aging Targets, Human-First Discovery Platform, Age-Related Disease, Healthy Lifespan.